Fonar Gross Margin 2012-2025 | FONR
Current and historical gross margin for Fonar (FONR) over the last 10 years. The current gross profit margin for Fonar as of September 30, 2025 is %.
| Fonar Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.11B | $0.04B | 40.95% |
| 2025-06-30 | $0.10B | $0.04B | 41.35% |
| 2025-03-31 | $0.10B | $0.04B | 41.75% |
| 2024-12-31 | $0.10B | $0.04B | 42.16% |
| 2024-09-30 | $0.10B | $0.04B | 43.14% |
| 2024-06-30 | $0.10B | $0.05B | 44.66% |
| 2024-03-31 | $0.10B | $0.05B | 45.63% |
| 2023-12-31 | $0.10B | $0.05B | 46.08% |
| 2023-09-30 | $0.10B | $0.05B | 46.53% |
| 2023-06-30 | $0.10B | $0.05B | 46.94% |
| 2023-03-31 | $0.10B | $0.05B | 47.42% |
| 2022-12-31 | $0.10B | $0.05B | 47.42% |
| 2022-09-30 | $0.10B | $0.05B | 48.45% |
| 2022-06-30 | $0.10B | $0.05B | 47.96% |
| 2022-03-31 | $0.10B | $0.05B | 47.96% |
| 2021-12-31 | $0.10B | $0.05B | 47.92% |
| 2021-09-30 | $0.09B | $0.04B | 47.31% |
| 2021-06-30 | $0.09B | $0.04B | 48.89% |
| 2021-03-31 | $0.09B | $0.04B | 51.16% |
| 2020-12-31 | $0.09B | $0.04B | 50.59% |
| 2020-09-30 | $0.09B | $0.04B | 50.59% |
| 2020-06-30 | $0.09B | $0.04B | 48.84% |
| 2020-03-31 | $0.09B | $0.04B | 47.13% |
| 2019-12-31 | $0.09B | $0.04B | 48.86% |
| 2019-09-30 | $0.09B | $0.04B | 48.86% |
| 2019-06-30 | $0.09B | $0.04B | 49.43% |
| 2019-03-31 | $0.09B | $0.04B | 48.84% |
| 2018-12-31 | $0.08B | $0.04B | 47.62% |
| 2018-09-30 | $0.08B | $0.04B | 48.19% |
| 2018-06-30 | $0.08B | $0.04B | 48.15% |
| 2018-03-31 | $0.08B | $0.04B | 49.38% |
| 2017-12-31 | $0.08B | $0.04B | 51.25% |
| 2017-09-30 | $0.08B | $0.04B | 51.28% |
| 2017-06-30 | $0.08B | $0.04B | 51.28% |
| 2017-03-31 | $0.08B | $0.04B | 50.00% |
| 2016-12-31 | $0.08B | $0.04B | 48.00% |
| 2016-09-30 | $0.08B | $0.04B | 48.00% |
| 2016-06-30 | $0.07B | $0.04B | 47.30% |
| 2016-03-31 | $0.07B | $0.04B | 48.61% |
| 2015-12-31 | $0.07B | $0.03B | 47.14% |
| 2015-09-30 | $0.07B | $0.03B | 46.38% |
| 2015-06-30 | $0.07B | $0.03B | 46.38% |
| 2015-03-31 | $0.07B | $0.03B | 46.38% |
| 2014-12-31 | $0.07B | $0.03B | 47.83% |
| 2014-09-30 | $0.07B | $0.03B | 47.14% |
| 2014-06-30 | $0.07B | $0.03B | 47.83% |
| 2014-03-31 | $0.07B | $0.03B | 45.71% |
| 2013-12-31 | $0.07B | $0.03B | 46.15% |
| 2013-09-30 | $0.06B | $0.03B | 47.37% |
| 2013-06-30 | $0.05B | $0.02B | 48.00% |
| 2013-03-31 | $0.04B | $0.02B | 48.84% |
| 2012-12-31 | $0.04B | $0.02B | 46.34% |
| 2012-09-30 | $0.04B | $0.02B | 45.00% |
| 2012-06-30 | $0.04B | $0.02B | 42.50% |
| 2012-03-31 | $0.04B | $0.02B | 43.24% |
| 2011-12-31 | $0.04B | $0.02B | 44.44% |
| 2011-09-30 | $0.04B | $0.02B | 45.71% |
| 2011-06-30 | $0.03B | $0.02B | 44.12% |
| 2011-03-31 | $0.04B | $0.02B | 42.86% |
| 2010-12-31 | $0.03B | $0.02B | 44.12% |
| 2010-09-30 | $0.03B | $0.01B | 41.18% |
| 2010-06-30 | $0.03B | $0.01B | 43.75% |
| 2010-03-31 | $0.03B | $0.01B | 42.42% |
| 2009-12-31 | $0.04B | $0.02B | 41.67% |
| 2009-09-30 | $0.04B | $0.02B | 46.15% |
| 2009-06-30 | $0.04B | $0.02B | 43.59% |
| 2009-03-31 | $0.04B | $0.02B | 40.54% |
| 2008-12-31 | $0.03B | $0.01B | 35.29% |
| 2008-09-30 | $0.03B | $0.01B | 29.41% |
| 2008-06-30 | $0.04B | $0.01B | 30.56% |
| 2008-03-31 | $0.04B | $0.01B | 27.03% |
| 2007-12-31 | $0.04B | $0.01B | 26.32% |
| 2007-09-30 | $0.04B | $0.01B | 22.86% |
| 2007-06-30 | $0.03B | $0.01B | 20.59% |
| 2007-03-31 | $0.03B | $0.01B | 20.00% |
| 2006-12-31 | $0.03B | $0.01B | 17.86% |
| 2006-09-30 | $0.03B | $0.01B | 19.35% |
| 2006-06-30 | $0.03B | $0.01B | 18.18% |
| 2006-03-31 | $0.05B | $0.01B | 26.42% |
| 2005-12-31 | $0.07B | $0.02B | 30.99% |
| 2005-09-30 | $0.09B | $0.03B | 33.71% |
| 2005-06-30 | $0.10B | $0.04B | 35.58% |
| 2005-03-31 | $0.10B | $0.04B | 37.00% |
| 2004-12-31 | $0.09B | $0.04B | 37.23% |
| 2004-09-30 | $0.08B | $0.03B | 37.35% |
| 2004-06-30 | $0.07B | $0.03B | 39.44% |
| 2004-03-31 | $0.06B | $0.03B | 40.63% |
| 2003-12-31 | $0.06B | $0.02B | 40.00% |
| 2003-09-30 | $0.05B | $0.02B | 39.62% |
| 2003-06-30 | $0.05B | $0.02B | 37.74% |
| 2003-03-31 | $0.05B | $0.02B | 40.38% |
| 2002-12-31 | $0.05B | $0.02B | 42.31% |
| 2002-09-30 | $0.05B | $0.02B | 41.30% |
| 2002-06-30 | $0.04B | $0.02B | 41.86% |
| 2002-03-31 | $0.04B | $0.01B | 35.00% |
| 2001-12-31 | $0.04B | $0.02B | 36.59% |
| 2001-09-30 | $0.04B | $0.02B | 36.59% |
| 2001-06-30 | $0.04B | $0.01B | 35.00% |
| 2001-03-31 | $0.04B | $0.01B | 35.00% |
| 2000-12-31 | $0.04B | $0.02B | 48.72% |
| 2000-09-30 | $0.04B | $0.02B | 47.37% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.115B | $0.104B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.189B | 14.81 |
| Haemonetics (HAE) | United States | $2.778B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |